Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier.

Sharma G, Modgil A, Zhong T, Sun C, Singh J.

Pharm Res. 2014 May;31(5):1194-209. doi: 10.1007/s11095-013-1242-x. Epub 2013 Nov 16.

PMID:
24242938
2.
3.

Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.

Tang J, Zhang L, Liu Y, Zhang Q, Qin Y, Yin Y, Yuan W, Yang Y, Xie Y, Zhang Z, He Q.

Int J Pharm. 2013 Sep 15;454(1):31-40. doi: 10.1016/j.ijpharm.2013.06.048. Epub 2013 Jul 10.

PMID:
23850793
4.

Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.

Zong T, Mei L, Gao H, Cai W, Zhu P, Shi K, Chen J, Wang Y, Gao F, He Q.

Mol Pharm. 2014 Jul 7;11(7):2346-57. doi: 10.1021/mp500057n. Epub 2014 Jun 11.

PMID:
24893333
5.

Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.

Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, Shang DW, Lou JN, Zhang LR, Zhang Q.

J Control Release. 2010 Jan 25;141(2):183-92. doi: 10.1016/j.jconrel.2009.09.020. Epub 2009 Sep 30.

PMID:
19799948
6.

Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier.

Fenart L, Buée-Scherrer V, Descamps L, Duhem C, Poullain MG, Cecchelli R, Dehouck MP.

Pharm Res. 1998 Jul;15(7):993-1000.

PMID:
9688050
7.

Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.

Aroui S, Brahim S, Waard MD, Kenani A.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):419-25. doi: 10.1016/j.bbrc.2009.11.073. Epub 2009 Nov 13.

PMID:
19914216
8.

Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.

Yuan M, Qiu Y, Zhang L, Gao H, He Q.

Drug Deliv. 2015 Jun 16:1-13. [Epub ahead of print]

PMID:
26036724
9.

Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma.

Zheng C, Ma C, Bai E, Yang K, Xu R.

Int J Clin Exp Med. 2015 Feb 15;8(2):1658-68. eCollection 2015.

10.

Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.

Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ.

J Pharm Pharm Sci. 2007;10(3):350-7.

11.

Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model.

Madhankumar AB, Slagle-Webb B, Wang X, Yang QX, Antonetti DA, Miller PA, Sheehan JM, Connor JR.

Mol Cancer Ther. 2009 Mar;8(3):648-54. doi: 10.1158/1535-7163.MCT-08-0853. Epub 2009 Mar 10.

12.
13.

Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.

Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL, Han M.

Biomaterials. 2013 Jul;34(22):5628-39. doi: 10.1016/j.biomaterials.2013.03.097. Epub 2013 Apr 26.

PMID:
23628475
14.

Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation.

Xu S, Liu Y, Tai HC, Zhu J, Ding H, Lee RJ.

Int J Pharm. 2011 Feb 14;404(1-2):205-10. doi: 10.1016/j.ijpharm.2010.10.053. Epub 2010 Nov 5. Erratum in: Int J Pharm. 2011 Jul 29;414(1-2):332.

15.
16.

Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.

Qin Y, Chen H, Zhang Q, Wang X, Yuan W, Kuai R, Tang J, Zhang L, Zhang Z, Zhang Q, Liu J, He Q.

Int J Pharm. 2011 Nov 28;420(2):304-12. doi: 10.1016/j.ijpharm.2011.09.008. Epub 2011 Sep 16.

PMID:
21945185
17.

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.

Li X, Ding L, Xu Y, Wang Y, Ping Q.

Int J Pharm. 2009 May 21;373(1-2):116-23. doi: 10.1016/j.ijpharm.2009.01.023. Epub 2009 Feb 4.

PMID:
19429296
18.

Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier model.

Sharma G, Modgil A, Sun C, Singh J.

J Pharm Sci. 2012 Jul;101(7):2468-78. doi: 10.1002/jps.23152. Epub 2012 Apr 19.

PMID:
22517732
19.

Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.

Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.

Mol Pharm. 2009 May-Jun;6(3):905-17. doi: 10.1021/mp800218q.

PMID:
19344115
20.

PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.

Yang Y, Yang Y, Xie X, Cai X, Zhang H, Gong W, Wang Z, Mei X.

Biomaterials. 2014 May;35(14):4368-81. doi: 10.1016/j.biomaterials.2014.01.076. Epub 2014 Feb 22.

PMID:
24565519
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk